| 1. |
Seaworth BJ, Griffith DE. Therapy of multidrug-resistant and extensively drug-resistant tuberculosis. Microbiol Spectr, 2017, 5(2): 1-2.
|
| 2. |
曾瑜, 楊曉妍, 周海龍, 等. 中國人群結核病疾病負擔的系統評價. 中國循證醫學雜志, 2018, 18(6): 570-579.
|
| 3. |
李瑜琴, 向敏, 陳玲, 等. 2013-2016 年遵義地區 870 例肺結核患者耐藥狀況分析. 中國防癆雜志, 2018, 40(6): 604-608.
|
| 4. |
張良基, 劉建南, 林立, 等. 不同診斷方法對結核性胸膜炎診斷價值對比. 中外醫療, 2017, (13): 28-30.
|
| 5. |
Patil CB, Dixit R, Gupta R. Thoracoscopic evaluation of 129 cases having undiagnosed exudative pleural effusions. Lung India, 2016, 33(5): 502-506.
|
| 6. |
Zhou X, Jiang P, Huan X, et al. Ultrasound-guided versus thoracoscopic pleural biopsy for diagnosing tuberculous pleurisy following inconclusive thoracentesis: a randomized, controlled trial. Med Sci Monit, 2018, 10(24): 7238-7248.
|
| 7. |
Edi ZM, Kadhem SBr, Jumaa MG. Molecular detection of RIF resistance in pulmonary and extrapulmonary specimens in Misan province-South of Iraq. Indian J Public Health Res Dev, 2019, 10(6): 797-800.
|
| 8. |
Saeed M, Ahmad M, Iram S. GeneXpert technology. A breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours. Saudi Med J, 2017, 38(7): 699-705.
|
| 9. |
陳效友. 《結核病分類》與《肺結核診斷》衛生行業新標準中關于結核性胸膜炎的解析. 中國防癆雜志, 2018, 40(3): 239-241.
|
| 10. |
中國惡性胸腔積液診斷與治療專家共識組. 惡性胸腔積液診斷與治療專家共識. 中華內科雜志, 2014, 53(3): 252-255.
|
| 11. |
唐曉媛, 左慧敏, 陳國峰, 等. 內科胸腔鏡治療結核性胸膜炎的意義. 中國內鏡雜志, 2018, 24(7): 1-4.
|
| 12. |
唐書福, 劉權賢, 張建勇, 等. 胸腔鏡聯合胸水 gene-Xpert 在結核性胸膜炎中的診斷評價. 中華醫院感染學雜志, 2018, 28(22): 3434-3437.
|
| 13. |
Prakash AK, Datta B, Tripathy JP. The clinical utility of cycle of threshold value of GeneXpert MTB/RIF (CBNAAT) and its diagnostic accuracy in pulmonary and extra-pulmonary samples at a tertiary care center in India. Indian J Tuberc, 2018, 65(4): 296-302.
|